Dataset Information

Adenosine 5 -triphosphate--creatine phosphotransferase from dystrophic mouse skeletal muscle. A genetic lesion associated with the catalytic-site thiol group.

ABSTRACT: 1. A column procedure for the purification of creatine kinase from normal and dystrophic mouse muscle is described. 2. The native enzymes are indistinguishable by various physical criteria and have mol.wt. about 80000. 3. The purified enzyme from dystrophic muscle is only half as active as the normal, contains only one thiol group readily alkylated by iodoacetamide instead of two and has one less free thiol group/mol. 4. Michaelis constants for MgATP and creatine are the same for both preparations. 5. The inhibitor constant for ADP at pH9.0 is different in the two enzymes and this may account for the different degrees of inhibition observed in vitro with the drug Laevadosin. 6. The enzyme from dystrophic muscle is protected by an equilibrium mixture of substrates against inhibition by iodoacetamide to a greater extent than the normal enzyme. 7. ;Fingerprinting' suggests one peptide difference between creatine kinases from normal and dystrophic muscle. 8. The possibility that this finding represents the primary lesion in dystrophy is discussed.

SUBMITTER: Hooton BT

PROVIDER: S-EPMC1265195 | biostudies-other | 1966 Sep

REPOSITORIES: biostudies-other

ACCESS DATA

Similar Datasets

Project description:1. The substrate combination creatine-MgADP does not significantly protect creatine kinase against inhibition by iodoacetamide in the absence of small anions. 2. Small anions can be divided into three groups according to the way in which they affect creatine kinase: I, acetate reversibly increases enzyme activity in the forward reaction but does not affect the rate of inhibition by iodoacetamide in the presence of creatine plus MgADP; II, planar anions and some halides (HCO(3) (-), HCO(2) (-), NO(3) (-), NO(2) (-), Cl(-), Br(-), F(-)) in the presence of creatine plus MgADP protect the enzyme from inhibition by iodoacetamide; III, tetrahedral anions (SO(4) (2-), HPO(4) (2-), ClO(4) (-), BF(4) (-)) and iodide do not affect the rate of inhibition by iodoacetamide in the presence of creatine plus MgADP but may decrease the protection by class II anions under these conditions. Anions of class II and class III also reversibly inhibit enzyme activity. 3. It is concluded that class II anions form a stable and inactive quaternary enzyme-creatine-MgADP-anion complex and this is responsible for the effect attributed by previous workers to the ternary complex lacking anion. Formation of this complex, particularly in the forward reaction, can lead to markedly non-linear enzyme progress curves. Some previous observations are re-appraised in the light of these findings. 4. From the behaviour of chloride and nitrate ions, and the marked lowering of the K(i) values for creatine and MgADP they produce, it is inferred that planar or monoatomic anions act in the quaternary complex by simulating the transferable phosphoryl group in the transition state (or another intermediate state) of the reaction. 5. It is suggested that, in the course of the reaction, the tetrahedral phosphate-binding site for the transferable phosphoryl group of the substrate (that also binds class II and class III anions) changes into a trigonal bipyramid site (also occupied by class II anions). This strains the phosphoryl group to adopt the transitional sp(3)d hybridized state and must contribute significantly to the low activation energy of the reaction. 6. Catalysis is deduced to proceed by an ;in line' transfer reaction and from the effects of class II anions it is possible to estimate the approximate dimensions of the anionic site in the transition-state complex. 7. The specific protecting effect of an equilibrium mixture of substrates against inhibition by iodoacetamide provides further evidence for the conformational change suggested above as a step in the catalytic process.

Dataset Information

Adenosine 5 -triphosphate--creatine phosphotransferase from dystrophic mouse skeletal muscle. A genetic lesion associated with the catalytic-site thiol group.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets